Baystreet Staff - Thursday, September 17, 2026 Conavi Medical Corp 12:52 PM EST - Conavi Medical Corp : Announced the publication of a peer-reviewed case report highlighting the clinical utility of hybrid intravascular ultrasound (“IVUS”) and optical coherence tomography (“OCT”) imaging in guiding treatment decisions following stent placement. Conavi Medical Corp shares V.CNVI are trading unchanged at $0.15. Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=CNVI%3ACC&qmodStoryID=8975126999474320